Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02962960” into the search
box and click “Search”.
• www.clinicaltrialsregister.eu Once you are on the website, click “Home and Search”, then
type “2016-003246-93” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D3461C00008”
into the search box, and click “Find a Study”.
Full study title: A Multicenter, Randomized, Double-Blind, Placebo-controlled,
Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety
of Anifrolumab Following Subcutaneous Administration in Adult Systemic Lupus
Erythematosus Subjects with Type 1 Interferon test High Result and Active Skin
Manifestations
National Clinical Trials number: NCT02962960
AstraZeneca Protocol Number: D3461C00008
AstraZeneca AB, sponsored this study and has its headquarters in 151 85 Södertälje,
Sweden
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting participants for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
11
Version 1.0 2019_12_19